Phase II trial of Liposomal Grb-2 (BP 100-1-01) combination salvage therapy in patients with chronic myeloid leukaemia
Phase of Trial: Phase II
Latest Information Update: 16 Mar 2016
At a glance
- Drugs Prexigebersen (Primary) ; Antineoplastics
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bio-Path Holdings
- 16 Mar 2016 According to Bio-Path Holdings media release, this trial expected to start in the second quarter of 2016.
- 16 Mar 2016 Planned initiation date changed from 31 Dec 2015 to 1 Apr 2016, as reported by Bio-Path Holdings media release.
- 21 Nov 2012 New trial record